Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh’s National Kala-azar Elimination Programme

BACKGROUND: Adverse effects of antileishmanial drugs can affect patients’ quality of life and adherence to therapy for visceral leishmaniasis (VL) and post-kala-azar dermal leishmaniasis (PKDL). In Bangladesh, there are 26 treatment centers that manage leishmaniasis cases coming from 100 endemic upa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Md. Sakhawat, Kumar, Amresh, Hossain, A.F.M Akhtar, Mahshin, Md., Sharma, Abhijit, Hossain, Md. Akter, Sharma, Varun, Haque, Rashidul, Shamsuzzaman, A.K.M, Maruf, Shomik, Ghosh, Prakash, Ahuja, Vivek, Mondal, Dinesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088425/
https://www.ncbi.nlm.nih.gov/pubmed/30099967
http://dx.doi.org/10.1186/s40249-018-0461-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088425/
https://www.ncbi.nlm.nih.gov/pubmed/30099967
http://dx.doi.org/10.1186/s40249-018-0461-0

Ejemplares similares